Vivaldis Pimoben (Pimobendan) Solo 5mg Tablet for Dogs
Inclusive of all taxes
Product Details
| Product type | Oral Chewable Tablets (Schedule H Prescription Drug) |
| Volume / Quantity | Available in a strip of 10 tablets or a box of 30 tablets |
| Target Species | Canines (Dogs of all breeds suffering from diagnosed cardiac illness) |
| Common Use Case | Long-term management of congestive heart failure (CHF) arising from dilated cardiomyopathy, atrioventricular/mitral valve insufficiency, and myxomatous mitral valve disease, as well as optimizing cardiac output and blood flow. |
Vivaldis Pimoben Solo 5mg is a premium, prescription-only veterinary cardiovascular medication formulated for the management of mild, moderate, or severe congestive heart failure (CHF) in dogs. It contains Pimobendan, a highly effective positive inotrope and phosphodiesterase III (PDE3) inhibitor that delivers vital dual-action cardiac support.
The advanced compound functions efficiently as an "inodilator" by directly strengthening the force of the heart muscle contractions while simultaneously relaxing and dilating peripheral blood vessels. This dual functionality reduces the workload on the heart, increases systemic cardiac output, and mitigates debilitating symptoms such as chronic coughing, fatigue, and lethargy. It is particularly prescribed for dogs suffering from dilated cardiomyopathy (DCM) or myxomatous mitral valve disease (MMVD). Administered orally on an empty stomach at 12-hour intervals, these chewable tablets provide essential, long-term therapeutic care to enhance the quality of life and increase survival rates in canine cardiac patients.